[go: up one dir, main page]

GB0618263D0 - Compound - Google Patents

Compound

Info

Publication number
GB0618263D0
GB0618263D0 GBGB0618263.8A GB0618263A GB0618263D0 GB 0618263 D0 GB0618263 D0 GB 0618263D0 GB 0618263 A GB0618263 A GB 0618263A GB 0618263 D0 GB0618263 D0 GB 0618263D0
Authority
GB
United Kingdom
Prior art keywords
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0618263.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medivir AB
Original Assignee
Medivir AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivir AB filed Critical Medivir AB
Priority to GBGB0618263.8A priority Critical patent/GB0618263D0/en
Publication of GB0618263D0 publication Critical patent/GB0618263D0/en
Priority to PCT/EP2007/059752 priority patent/WO2008034781A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0618263.8A 2006-09-18 2006-09-18 Compound Ceased GB0618263D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0618263.8A GB0618263D0 (en) 2006-09-18 2006-09-18 Compound
PCT/EP2007/059752 WO2008034781A1 (en) 2006-09-18 2007-09-17 Cysteine protease inhibitor salt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0618263.8A GB0618263D0 (en) 2006-09-18 2006-09-18 Compound

Publications (1)

Publication Number Publication Date
GB0618263D0 true GB0618263D0 (en) 2006-10-25

Family

ID=37310051

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0618263.8A Ceased GB0618263D0 (en) 2006-09-18 2006-09-18 Compound

Country Status (2)

Country Link
GB (1) GB0618263D0 (en)
WO (1) WO2008034781A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4613273A1 (en) 2024-03-06 2025-09-10 Vetbiolix Treatment of bone loss

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005019971D1 (en) * 2004-01-08 2010-04-29 Medivir Ab INHIBITORS OF CYSTONE PROTEASE

Also Published As

Publication number Publication date
WO2008034781A1 (en) 2008-03-27

Similar Documents

Publication Publication Date Title
ZA200808639B (en) Oxadiazolidinedione compound
IL194438A0 (en) Diarylthiohydantoin compounds
GB2441396B (en) Indoline-sulfonamides compounds
GB0602424D0 (en) Compounds
GB0602046D0 (en) Compounds
EP1984379A4 (en) Anti-arenaviral compounds
EP2000469A4 (en) Acylaminopiperidine compound
GB0625594D0 (en) Compounds
GB0602778D0 (en) Novel compound
EP2082022A4 (en) Compounds
IL197078A0 (en) Ouinolinylmethyl compounds
GB0607096D0 (en) Compound
ZA200808549B (en) Naphthalenedione compounds
GB0604142D0 (en) Compound
GB0602042D0 (en) Compounds
AP2009004767A0 (en) Cubstituted azolin-2-yl-amino compounds
GB0614046D0 (en) Compounds
EP1973905A4 (en) Compounds
GB0602412D0 (en) Compounds
GB0600427D0 (en) Compounds
GB0618263D0 (en) Compound
GB0608825D0 (en) Compounds
GB0607251D0 (en) Compound
GB0606932D0 (en) Compound
GB0615531D0 (en) Compound

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)